Diet and nutritional aspects in systemic lupus erythematosus

Revista Brasileira de Reumatologia

Volumn 52, Issue 3, 2012, Pages 384-408

  Klack, Karin ^a   Bonfa, Eloisa ^a   Neto, Eduardo Ferreira Borba ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diet; Nutrition assessment; Nutrition programs; Systemic lupus erythematosus

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CANAVANINE; COPPER; IRON; ISOFLAVONE DERIVATIVE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RETINOL; SELENIUM; SODIUM; TAURINE; VITAMIN B COMPLEX; VITAMIN D; ZINC;

CALORIC INTAKE; COMORBIDITY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; ENERGY CONSUMPTION; FAT INTAKE; FIBER; HUMAN; MEDICAL DECISION MAKING; MINERAL INTAKE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

DIETARY PROTEINS; FATTY ACIDS, UNSATURATED; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MINERALS; NUTRITION PROCESSES; VITAMINS;

EID: 84861954113     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Borba EF, Latorre LC, Brenol JC, Kayser C, Silva NA, Zimmermann AF et al. Consenso de lúpus eritematoso sistêmico. Rev Bras Reumatol 2008; 48(4):196-207.
2. Bruce IN. Not only...but also: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44(12):1492-1502.
3. Borba EF, Bonfá E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997; 6(6):533-539.
4. Borba EF, Bonfá E, Vinagre CG, Ramires JA, Maranhão RC. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 2000; 43(5):1033-1040.
5. Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004; 50(11):3610-3615.
6. Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with upregulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003; 48(9):2533-2540.
7. Petri M, Lakata C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994; 96(3):254-259.
8. Caetano MC, Ortiz TT, Terreri MT, Sarni RO, Silva SG, Souza FI et al. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erithematosus. J Pediatr 2009; 85(6):509-515.
9. Azevedo GD, Gadelha RG, Vilar MJ. Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA. Ann Rheum Dis 2007; 66(11):1542.
10. Cunha BM, Klumb EM, Moura JQ, Santos A, Pinheiro GRC, Albuquerque EMN et al. Frequência de síndrome metabólica em pacientes com nefrite lúpica. Rev Bras Reumatol 2008; 48(5):267-273.
11. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintane A, Raggi P et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007; 66(2):208-214.
12. dos Santos F de M, Borges MC, Correia MI, Telles RW, Lanna CC. Assessment of nutritional status and physical activity in systemic lupus erythematosus patients. Rev Bras Reumatol 2010; 50(6):631-638.
13. Shah M, Coyle Y, Kavanaugh A, Adams-Huet B, Lipsky PE. Development and initial evaluation of a culturally sensitive cholesterol-lowering diet program for Mexican and African American patients with systemic lupus erythematosus. Arthritis Care Res 2000; 13(4):205-212.
14. Shah M, Kavanaugh A, Coyle Y, Adams-Huet B, Lipsky PE. Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol 2002; 29(10):2122-2128.
15. Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 2010; 172(2):205-216.
16. Patavino T, Brady DM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev 2001; 6(5):460-471.
17. Hong YH, Huang CJ, Wang SC, Lin BF. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice. Lupus 2009; 18(3):206-215.
18. Maki PA, Newberne PM. Dietary lipids and immune function. J Nutr 1992; 122(3 Suppl):610-614.
19. Selmi C, Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010; 9(5):A267-A270.
20. Brown AC. Lupus erythematosus and nutrition: a review of the literature. J Ren Nutr 2000; 10(4):170-183.
21. Leiba A, Amital H, Gershwin ME, Shoenfeld Y. Diet and lupus. Lupus 2001; 10(3):246-248.
22. Petri M. Diet and systemic lupus erythematosus: from mouse and monkey to woman? Lupus 2001; 10(11):775-777.
23. Chandrasekar B, Troyer DA, Venkatraman JT, Fernandes G. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression. J Autoimmun 1995; 8(3):381-393.
24. Trumbo P, Schlicker S, Yates AA, Poos M; Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. J Am Diet Assoc 2002; 102(11):1621-1630. [Erratum in: J Am Diet Assoc 2003; 103(5):563]
25. US National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Washington, DC: National Heart, Lung and Blood Institute, 1998.
26. British Nutrition Foundation. Obesity. London: Blackwell Science, 1999.
27. National Institutes of Health, National Heart, Lung, and Blood Institute. Obesity education initiative. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6(Suppl 2):51S-209S. [Erratum in: Obes Res 1998; 6(6):464]
28. United States Department of Agriculture. USDA National Nutrient Database For Standard Reference Release 18. Agricultural Research Service. [Available from: http://www.nal.usda.gov/fnic/foodcomp/Data/SR18/sr18.html]
29. Mannoor MK, Shimabukuro I, Tsukamotoa M, Watanabe H, Yamaguchi K, Sato Y. Honeybee royal jelly inhibits autoimmunity in SLE-prone NZB x NZW F1 mice. Lupus 2009; 18(1):44-52.
30. Milovanov Iu S, Lysenko LV, Milovanova Llu, Dobrosmyslov IA. The role of balanced low-protein diet in inhibition of predialysis chronic kidney disease progression in patients with systemic diseases. Ter Arkh 2009; 81(8):52-57.
31. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ 2008; 336(7654):1185-1189.
32. Hong Y, Wang T, Huang C, Cheng W, Lin B. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice. Lupus 2008; 17(9):814-821.
33. Zhao JH, Sun SJ, Horiguchi H, Arao Y, Kanamori N, Kikuchi A et al. A soy diet accelerates renal damage in autoimune MRL/Mp-lpr/lpr mice. Int Immunopharmacol 2005; 5(11):1601-1610.
34. Akaogi J, Barker T, Kuroda Y, Nacionales DC, Yamasaki Y, Stevens BR et al. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev 2006; 5(6):429-435.
35. Huang CY, Hsu TC, Kuo WW, Wu SP, Lin YM, Yen CY et al. Beneficial effects of taurine on cardiac abnormality in NZB/W F1 mice fed with a high-cholesterol diet. J Agric Food Chem 2009; 57(18): 8635-8642.
36. Hsu TC, Chiang SY, Wu JH, Tsai CC, Huang CY, Chen YC et al. Treatment with taurine attenuates hepatic apoptosis in NZB/W F1 mice fed with a high-cholesterol diet. J Agric Food Chem 2008; 56(20):9685-9691.
37. Kien CL. Dietary interventions for metabolic syndrome: role of modifying dietary fats. Curr Diab Rep 2009; 9(1):43-50.
38. Halen BH, Lourenço EV, McMahon M, Skaggs B, Le E, Anderson M et al. Pro-inflammatory high density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus 2010; 19(8):913-917.
39. Pestka JJ. N-3 polyunsaturated fatty acids and autoimmunemediated glomerulonephritis. Prostaglandins Leukot Essent Fatty Acids 2010; 82(4-6):251-258.
40. Halade GV, Rahman MM, Bhattacharya A, Barnes JL, Chandrasekar B, Fernandes G. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J Immunol 2010; 184(9):5280-5286.
41. Fassett RG, Gobe GC, Peake JM, Coombes JS. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 2010; 56(4):728-742.
42. Mohan IK, Das UN. Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 1997; 56(3):193-198.
43. Venkatraman JT, Chu WC. Effects of dietary omega-3 and omega-6 lipids and vitamin E on proliferative response, lymphoid cell subsets, production of cytokines by spleen cells, and splenic protein levels for cytokines and oncogenes in MRL/MpJ-lpr/lpr mice. J Nutr Biochem 1999; 10(10):582-597.
44. MacLean CH, Mojica WA, Morton SC, Pencharz J, Hasenfeld Garland R, Tu W et al. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evid Rep Technol Assess (Summ) 2004; (89):1-4.
45. Minami Y, Sasaki T, Arai Y, Kurisu Y, Hisamichi S. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients. J Rheumatol 2003; 30(4):747-754.
46. Duffy EM, Meenagh GK, McMillan SA, Strain JJ, Hannigan BM, Bell AL. The clinical effect of dietary supplementation with omega-3 fish oil and/or copper in systemic lupus erythematosus. J Rheumatol 2004; 31(8):1551-1556.
47. Chou CT. Alternative therapies: what role do they have in the management of lupus? Lupus 2010; 19(12):1425-1429.
48. Kinoshita K, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S et al. Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis 2010; 55(2):344-347.
49. Ikeda T, Nishide T, Ohtani T, Furukawa F. The effects of vitamin A derivative etretinate on the skin of MRL mice. Lupus 2005; 14(7):510-516.
50. Cutolo M, Otsa K. Vitamin D, immunity and lupus. Lupus 2008; 17(1):6-10.
51. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67(4):530-535.
52. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5(2):114-1147.
53. Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61(10):1387-1395.
54. Knott HM, Martínez JD. Innovative management of lupus erythematosus. Dermatol Clin 2010; 28(3):489-499.
55. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155(2):260-265.
56. Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010; 19(1):13-139.
57. Lane NE. Vitamin D and systemic lupus erythematosus: bones, muscles, and joints. Curr Rheumatol Rep 2010; 12(4):259-263.
58. Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau C, Gladman D et al. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. J Rheumatol 2010; 37(1):87-90.
59. Tam LS, Li EK, Leung VY, Griffith JF, Benzie IF, Lim PL et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind placebo controlled pilot study. J Rheumatol 2005; 32(2):275-282.
60. Varghese B, Haase N, Low PS. Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. Mol Pharm 2007; 4(5):679-685.
61. Minami Y, Hirabayashi Y, Nagata C, Ishii T, Harigae H, Sasaki T. Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients. J Epidemiol 2011. [Epub 2011 Apr 23]
62. Shah M, Adams-Huet B, Kavanaugh A, Coyle Y, Lipsky P. Nutrient intake and diet quality in patients with systemic lupus erythematosus on a culturally sensitive cholesterol lowering dietary program. J Rheumatol 2004; 31(1):71-75.
63. Ardoin SP, Sandborg C, Schanberg LE. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus 2007; 16(8):618-626.
64. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans, 2005. [Available from: http://www.health.gov/DietaryGuidelines/dga2005/document]
65. Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004; 164(4):370-376.
66. Ajani UA, Ford ES, Mokdad AH. Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey data. J Nutr 2004; 134(5):1181-1185.
67. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, et al. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 2005; 82(2):471-476.
68. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panapolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 2010; 62(7):993-1001.
69. Leiter LM, Reuhl KR, Racis SP Jr, Sherman AR. Iron status alters murine systemic lupus erythematosus. J Nutr 1995; 125(3):474-484.
70. Falcão S, Barros R, Mateus M, Nero P, de Matos AA, Pimentão JB et al. Lúpus eritematoso sistêmico e anemia. Acta Reumatol Port 2007; 32(1):73-79.